Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Part of paid clinical trials in New York, New York.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT05940272
- Status
- Recruiting
Conditions
- DLBCL - Diffuse Large B Cell Lymphoma
- Large B-cell Lymphoma
- Large-cell Lymphoma
- Lymphoma
- Lymphoma, B-Cell
- Mediastinal B-Cell Diffuse Large Cell Lymphoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Hematolo-GIST Training — BEHAVIORALHematologist will participate in a group Hematolo-GIST training provided remotely via the study team.
- Participants Appointment — BEHAVIORALParticipants will meet with Hematolo-GIST trained hematologists. Participants will consent to having their appointment audio-recorded on password-protected devices or MSK approved secure platforms.
Study Details
The purpose of this study is to develop and test a new communication training intervention called Hematolo-GIST to help oncologists communicate with patients about their lymphoma diagnosis and advance care planning.
Key Dates
- Start date
- Jul 3, 2023
- Status verified
- Oct 2025
- Primary completion
- Jul 3, 2028
- Completion
- Jul 3, 2028
Study Design
- Enrollment
- 48 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: HematologistsHematologists will be recruited from the lymphoma clinics at MSK
- Experimental: Participants PatientsParticipant patients are being treated by a hematologic oncologist participating in this study
Primary Outcome Measure
Feasibility of the Hematolo-GIST intervention among hematologists and participants [ Time Frame: Up to 1 year ]
Central Contacts
- Kelly McConnell, PhD646-888-0026
- Revecca Saracino, PhD646-888-0263
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center (All protocol activities) | New York | New York | 10065 | Kelly McConnell, PhD 646-888-0026 |
| NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only) | New York | New York | 10065 | Alan Astrow, MD 646-962-2330 |
Find similar trials in New York, NY
Related Studies
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado
- Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Miami, Florida